SVP Clinical Development Jeffrey Wiezorek sold $497K of Kite Pharma, Inc.

Sold$497,379

$55.26Price

9,000Shares

−40%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Fri, Jan 15. Filed Tue, Jan 19, 3:24 PM ET, during the session. Not investment advice.